 Connection
Michael Leibowitz to Head and Neck Neoplasms
This is a "connection" page, showing publications Michael Leibowitz has written about Head and Neck Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.802 |
|
|
|
-
Leibowitz MS, Srivastava RM, Andrade Filho PA, Egloff AM, Wang L, Seethala RR, Ferrone S, Ferris RL. SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells. Clin Cancer Res. 2013 Feb 15; 19(4):798-808.
Score: 0.265
-
Leibowitz MS, Ferris RL. Recurrence in head and neck squamous cell carcinoma. Editorial. Cancer. 2008 Aug 15; 113(4):671-3.
Score: 0.194
-
Leibowitz MS, Nayak JV, Ferris RL. Head and neck cancer immunotherapy: clinical evaluation. Curr Oncol Rep. 2008 Mar; 10(2):162-9.
Score: 0.188
-
Leibowitz MS, Andrade Filho PA, Ferrone S, Ferris RL. Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes. Cancer Immunol Immunother. 2011 Apr; 60(4):525-35.
Score: 0.057
-
Davidson HC, Leibowitz MS, Lopez-Albaitero A, Ferris RL. Immunotherapy for head and neck cancer. Oral Oncol. 2009 Sep; 45(9):747-51.
Score: 0.051
-
Couch ME, Ferris RL, Brennan JA, Koch WM, Jaffee EM, Leibowitz MS, Nepom GT, Erlich HA, Sidransky D. Alteration of cellular and humoral immunity by mutant p53 protein and processed mutant peptide in head and neck cancer. Clin Cancer Res. 2007 Dec 01; 13(23):7199-206.
Score: 0.046
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|